127 related articles for article (PubMed ID: 8621698)
1. Structural studies of a peptide activator of human lecithin-cholesterol acyltransferase.
Buchko GW; Treleaven WD; Dunne SJ; Tracey AS; Cushley RJ
J Biol Chem; 1996 Feb; 271(6):3039-45. PubMed ID: 8621698
[TBL] [Abstract][Full Text] [Related]
2. Conformation of two peptides corresponding to human apolipoprotein C-I residues 7-24 and 35-53 in the presence of sodium dodecyl sulfate by CD and NMR spectroscopy.
Rozek A; Buchko GW; Cushley RJ
Biochemistry; 1995 Jun; 34(22):7401-8. PubMed ID: 7779782
[TBL] [Abstract][Full Text] [Related]
3. Conformation of human serum apolipoprotein A-I(166-185) in the presence of sodium dodecyl sulfate or dodecylphosphocholine by 1H-NMR and CD. Evidence for specific peptide-SDS interactions.
Wang G; Treleaven WD; Cushley RJ
Biochim Biophys Acta; 1996 Jun; 1301(3):174-84. PubMed ID: 8664326
[TBL] [Abstract][Full Text] [Related]
4. Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.
Pownall HJ; Hu A; Gotto AM; Albers JJ; Sparrow JT
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3154-8. PubMed ID: 6774331
[TBL] [Abstract][Full Text] [Related]
5. The helix-hinge-helix structural motif in human apolipoprotein A-I determined by NMR spectroscopy.
Wang G; Sparrow JT; Cushley RJ
Biochemistry; 1997 Nov; 36(44):13657-66. PubMed ID: 9354635
[TBL] [Abstract][Full Text] [Related]
6. Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase.
Buchko GW; Rozek A; Kanda P; Kennedy MA; Cushley RJ
Protein Sci; 2000 Aug; 9(8):1548-58. PubMed ID: 10975576
[TBL] [Abstract][Full Text] [Related]
7. Conformational studies of an amphipathic peptide corresponding to human apolipoprotein A-II residues 18-30 with a C-terminal lipid binding motif EWLNS.
Buchko GW; Wang G; Pierens GK; Cushley RJ
Int J Pept Protein Res; 1996 Jul; 48(1):21-30. PubMed ID: 8844260
[TBL] [Abstract][Full Text] [Related]
8. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
[TBL] [Abstract][Full Text] [Related]
9. Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides.
Subbarao NK; Fielding CJ; Hamilton RL; Szoka FC
Proteins; 1988; 3(3):187-98. PubMed ID: 3255105
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
[TBL] [Abstract][Full Text] [Related]
12. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
[TBL] [Abstract][Full Text] [Related]
13. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
Datta G; Chaddha M; Hama S; Navab M; Fogelman AM; Garber DW; Mishra VK; Epand RM; Epand RF; Lund-Katz S; Phillips MC; Segrest JP; Anantharamaiah GM
J Lipid Res; 2001 Jul; 42(7):1096-104. PubMed ID: 11441137
[TBL] [Abstract][Full Text] [Related]
14. Effect of end group blockage on the properties of a class A amphipathic helical peptide.
Venkatachalapathi YV; Phillips MC; Epand RM; Epand RF; Tytler EM; Segrest JP; Anantharamaiah GM
Proteins; 1993 Apr; 15(4):349-59. PubMed ID: 8460106
[TBL] [Abstract][Full Text] [Related]
15. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP
Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091
[TBL] [Abstract][Full Text] [Related]
16. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.
Roosbeek S; Vanloo B; Duverger N; Caster H; Breyne J; De Beun I; Patel H; Vandekerckhove J; Shoulders C; Rosseneu M; Peelman F
J Lipid Res; 2001 Jan; 42(1):31-40. PubMed ID: 11160363
[TBL] [Abstract][Full Text] [Related]
17. Lecithin cholesterol acyltransferase (LCAT) activity in the presence of Apo-AI-derived peptides exposed to disorder-order conformational transitions.
Aguilar-Espinosa SL; Mendoza-Espinosa P; Delgado-Coello B; Mas-Oliva J
Biochem Biophys Res Commun; 2013 Nov; 441(2):469-75. PubMed ID: 24383078
[TBL] [Abstract][Full Text] [Related]
18. Structure and topography of the membrane-binding C2 domain of factor VIII in the presence of dodecylphosphocholine micelles.
Veeraraghavan S; Baleja JD; Gilbert GE
Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):549-55. PubMed ID: 9601086
[TBL] [Abstract][Full Text] [Related]
19. Conformations of human apolipoprotein E(263-286) and E(267-289) in aqueous solutions of sodium dodecyl sulfate by CD and 1H NMR.
Wang G; Pierens GK; Treleaven WD; Sparrow JT; Cushley RJ
Biochemistry; 1996 Aug; 35(32):10358-66. PubMed ID: 8756691
[TBL] [Abstract][Full Text] [Related]
20. Conformation of human apolipoprotein C-I in a lipid-mimetic environment determined by CD and NMR spectroscopy.
Rozek A; Sparrow JT; Weisgraber KH; Cushley RJ
Biochemistry; 1999 Nov; 38(44):14475-84. PubMed ID: 10545169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
